- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- July 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2025
- 284 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2025
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- July 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- April 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Drug Pipelines
- December 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €4772EUR$5,000USD£3,998GBP

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy.
Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease.
Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more